BioNTech is a biotechnology company based in Germany, known for its innovative work in the development of immunotherapies, particularly in the field of mRNA technology. Founded in 2008, BioNTech focuses on the discovery and development of personalized cancer treatments as well as infectious disease therapies. The company gained global recognition for its collaboration with Pfizer in producing one of the first COVID-19 vaccines authorized for emergency use. The vaccine, based on messenger RNA (mRNA) technology, works by instructing cells to produce a protein that prompts an immune response against the virus. BioNTech is committed to advancing medical science and improving patient outcomes through cutting-edge research and development in various areas of medicine.
BioNTech is transitioning from COVID-19 vaccines to innovative cancer therapies using mRNA technology, aiming for market launch by 2026. Revenue dropped from €3.8 billion in 2023 to €2.75 billion in…